Vedere Bio

0 followers

‌

Vedere Bio II, Inc.® is a company developing next generation ocular gene therapies designed for vision restoration and preservation for patients with vision loss due to photoreceptor death.

Industries

Headquarters

Employees

Links

Org chart

Gina Consylman

CFO

Mike Murtagh

SVP, Regulatory Affairs

Martina Schinke

VP, Program Leader

Daniel Zimmer

Senior Director, Program Lead

Ellen Zyrkowski

Associate Director, HR & Communications

Soraya Bekkali, MD

Non Executive Director

Xiaozhi Ren (任小峙) Ph.D.

Director, CMC, Cell Line and Process Development

Karen Guerin

Senior Director, Discovery Research

Teams

Leadership Team

4 members

Research and Development

5 members

Similar companies

Inceptive

5 followers

Vaxcyte

2 followers

Kyverna Therapeutics

5 followers

Obsidian Therapeutics

1 follower

Cargo

1 follower

Chroma Medicine

1 follower

Slingshot Biosciences

1 follower

Araceli Biosciences

1 follower

Generate Biomedicines

3 followers

SolarBioTech

1 follower

Cellares

2 followers

Discover companies